Abiopharma

Inovio - INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

New Form 4 - Altimmune, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073627 Size: 6 KB

New Form 4 - Tilray Brands, Inc. Filed: 2025-08-04 AccNo: 0001171843-25-004990 Size: 9 KB

Addus HomeCare Announces Second Quarter 2025 Financial Results

Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results

CVRx Reports Second Quarter 2025 Financial and Operating Results

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences - Castle Biosciences Reports Second Quarter 2025 Results

New Form 4 - Altimmune, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073624 Size: 5 KB

New Form 144 - INCYTE CORP Filed: 2025-08-04 AccNo: 0001950047-25-005377 Size: 7 KB

New Form 8-K - TACTILE SYSTEMS TECHNOLOGY INC Filed: 2025-08-04 AccNo: 0001558370-25-010096 Size: 792 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Best Brands For Laptops in 2025

Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025